Here are four things to know.
1. CHS shares tumbled midday March 13 after the Reorg Research report was released.
2. CHS shares ended the day down 9.8 percent at $4.49 per share.
3. According to the Reorg Research report, attorneys from Davis Polk had a call with more than a dozen of CHS’ loan lenders March 9 to discuss potential restructuring options the company could pursue.
4. Sources told Reorg Research the lenders do not plan to challenge CHS’ latest amendment to its debt.
Access the full Reorg Research report here.
More articles on healthcare finance:
Wisconsin hospital at risk of losing Medicare contract over injuries to babies
Wyoming hospital resolves 20 malpractice suits that pushed it into bankruptcy
Miami hospital files for bankruptcy: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
